Group 1 - The first meeting of the employee stock ownership plan (ESOP) was held on February 6, 2026, with 37 participants representing 175,322 shares, which is 100% of the total shares in the first ESOP [2][3] - The meeting approved the establishment of a management committee for the ESOP, consisting of three members, to oversee the plan's implementation and protect the rights of the shareholders [3][4] - The committee members elected are Cheng Shifeng, Huang Tianchuan, and Cheng Xinhua, all of whom are participants in the ESOP and have no relationships with major shareholders or company executives [4] Group 2 - The management committee was authorized to handle various matters related to the ESOP, including convening meetings, managing daily operations, and representing shareholders in exercising their rights [5] - The ESOP has a total subscription of 175,322 shares, with a total investment of 6.1415 million yuan, and the shares were acquired at a price of 35.03 yuan per share [12][13] - The shares transferred to the ESOP account on February 6, 2026, represent 0.16% of the company's total share capital, and the plan has a lock-up period of 12 months [10][13]

Overview - Tianjin Lifeng Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for the listing application of Adenine Phosphate raw material [2] Product Information - The product, Adenine Phosphate, is a chemical raw material with a molecular weight of 233.12 and a molecular formula of C5H5N5·H3PO4 [2] - It is used clinically to prevent and treat leukopenia caused by various reasons, particularly in cases related to chemotherapy, radiation therapy, and benzene poisoning [2] Impact on the Company - The approval of this product's listing application is expected to enhance the company's market competitiveness by creating industrial synergy with its formulation products [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600497 证券简称：驰宏锌锗 公告编号：临2026-007 云南驰宏锌锗股份有限公司 关于董事会延期换届的提示性公告 公司董事会延期换届不会影响公司的正常运营，亦不会导致独立董事任职时间超过6年的情形。公司将 积极推进董事会换届工作进程，并严格按照规定及时履行信息披露义务。 特此公告。 云南驰宏锌锗股份有限公司董事会 2026年2月7日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 云南驰宏锌锗股份有限公司（以下简称"公司"）第八届董事会任期将于2026年2月7日届满。鉴于公司新 一届董事会董事候选人的提名工作尚未完成，为保证公司董事会工作的连续性和稳定性，公司董事会的 换届选举工作将延期进行，同时公司董事会各专门委员会、高级管理人员的任期亦相应顺延。 在新一届董事会完成换届选举前，公司第八届董事会、董事会各专门委员会全体成员及高级管理人员将 严格按照相关法律法规和《公司章程》等有关规定，继续履行相应的职责和义务。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 ACM RESEARCH, INC.（以下简称"美国ACMR"或"出让方"）保证向盛美半导体设备（上海）股份有限 公司（以下简称"盛美上海"或"公司"）提供的信息内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其真实性、准确性和完整性依法承担法律责任。 本次权益变动后，出让方美国ACMR及其一致行动人合计持有公司股份比例由74.84%减少至73.72%， 持有公司权益比例变动触及1%的整数倍。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: 一、出让方情况 (一)出让方基本情况 截至2026年1月30日，出让方所持公司股份的数量、比例情况如下： ●本次询价转让的价格为160.00元/股，转让的股票数量为4,801,648股。 ●公司控股股东美国ACMR参与本次询价转让。美国ACMR为盛美上海实际控制人、董事长HUI WANG 控制的公司，本次询价转让的出让方与HUI WANG及公司董事、总经理王坚为一致行动人。 ●公司不存在《上海证券交易所科创板股票上市规则》第八章第二节规定的应当披露而未披露的经营风 险，不存在其他应 ...

Market Updates - The Shanghai and Shenzhen stock exchanges announced the holiday schedule for the 2026 Spring Festival, with a break from February 15 to February 23, resuming trading on February 24 [1] - The Shanghai Futures Exchange adjusted the price limits and margin requirements for various futures contracts, including copper, aluminum, and gold, effective from February 9 [2] Company News - Runze Technology announced plans to issue convertible bonds to acquire assets, with trading suspended from February 6 for up to 10 trading days [4] - Tianqi Model is planning a major asset restructuring through the issuance of shares and cash to acquire equity in Dongshi Automotive Technology Group, with trading suspended from February 6 [5] - *ST Cube reported a significant stock price increase of 314.93% from January 20 to February 5, leading to a trading suspension for verification due to potential market volatility [5] - Jiangfeng Electronics plans to acquire control of Beijing Kaide Quartz Co., with trading resuming on February 6 [6] - JinkoSolar clarified that it has not engaged in any business with SpaceX and has no current orders related to "space photovoltaics," which has not impacted its financial performance [8] - Jinfu Technology intends to acquire 51% stakes in two companies for a total consideration of up to 714 million yuan, with a share transfer agreement in place [9] Industry Insights - CITIC Securities reported that the automotive industry may face profit margin pressures in Q1 2026 due to rising costs of storage and battery materials, with potential impacts from lithium carbonate price increases [10] - Galaxy Securities highlighted that AI's benefits are primarily seen in improved efficiency and cost reduction across platforms and content production, suggesting a focus on internet and AI-related stocks [11]

2月5日晚，国轩高科披露向特定对象发行A股股票预案，拟定增募资不超过50亿元，在扣除发行费用后，拟全部用于年产20GWh动力电池项目、国轩高科 20GWh新能源电池基地项目、新型锂离子电池（20GWh）智造基地项目及补充流动资金。 国轩高科称，随着新能源产业爆发式增长，新能源锂电池市场的需求日趋扩大，动力电池及储能电池的出货量持续增长。通过实施此次募集资金投资项 目，公司能够进一步扩大新质产能，为新老客户提供稳定可靠的供货保障。 Wind数据显示，截至2月5日收盘，国轩高科股价报37.14元/股，最新市值为674亿元。 | 序号 | 投资项目名称 | 总投资金额 | 拟使用募集资金 | | --- | --- | --- | --- | | | 年产20GWh动力电池项目 | 500,072.00 | 200,000.00 | | 2 | 国轩高科20GWh新能源电池基地项目 | 400,036.00 | 100,000.00 | | 3 | 新型锂离子电池(20GWh)智造基地项目 | 400,000.00 | 100,000.00 | | 4 | 补充流动资金 | 100,000.00 | 100,000 ...

Group 1 - The company plans to acquire a 49.00% stake in Jiangsu Jinyuan High-end Equipment Co., Ltd. from Ge Yanming through a combination of issuing shares and cash payment, while also raising supporting funds [2][3] - This transaction is classified as a related party transaction and is not expected to constitute a major asset restructuring or a restructuring listing [3] - The company has been actively advancing the transaction since the disclosure of the preliminary plan, and as of the announcement date, no new factors have been identified that could lead to the withdrawal or significant changes to the transaction [2][5] Group 2 - The company held its 11th meeting of the 2nd Board of Directors on December 8, 2025, where it approved the related proposals for the transaction, with details published on December 9, 2025 [4] - As of January 8, 2026, the company disclosed progress on the transaction, indicating that the audit and evaluation work related to the transaction is still ongoing [4][5] - The company will convene another board meeting to review the transaction once the audit and evaluation are completed, and will comply with legal and regulatory requirements for subsequent procedures and disclosures [5]

本公司及董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 2026年1月27日，山东联科科技股份有限公司（以下简称"公司"）召开第三届董事会第十三次会议，审 议通过了公司《关于〈山东联科科技股份有限公司2026年限制性股票激励计划（草案）〉及其摘要的议 案》等相关议案。具体内容详见公司于2026年1月27日刊载在巨潮资讯网（www.cninfo.com.cn）披露的 相关公告。 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《深圳证券交易所上市公司自律监 管指南第1号一一业务办理》等法律法规和《山东联科科技股份有限公司2026年限制性股票激励计划 （草案）》等相关规定，公司在内部对2026年限制性股票激励计划（以下简称"本激励计划"）授予的激 励对象（以下简称"激励对象"）姓名及职务进行了公示。董事会薪酬与考核委员会结合本次公示情况对 本激励计划的激励对象进行了核查，现说明如下： 一、激励对象名单的公示情况 1、公示内容：2026年限制性股票激励计划拟激励对象的姓名和职务。 2、公示时间：2026年1月27日至20 ...

Group 1 - The company disclosed that its actual controller, Ms. Wang Shaoyong, plans to reduce her shareholding by a maximum of 1,673,400 shares (1% of total share capital) through centralized bidding and 3,346,900 shares (2% of total share capital) through block trading within three months after the announcement [1] - As of February 5, 2026, Ms. Wang has reduced her holdings by 1,143,100 shares between February 3 and February 4, 2026, resulting in a change in her and her concerted action parties' total shareholding from 34.61% to 33.80%, triggering a 1% threshold change [1] - The reduction in shareholding is consistent with the previously disclosed reduction plan and does not trigger a mandatory tender offer or affect the company's governance structure and ongoing operations [2] Group 2 - The company will continue to monitor the progress of the share reduction plan and will fulfill its information disclosure obligations as required by relevant regulations [2] - The "Hua Ti Convertible Bonds" are still in the conversion period, and there is uncertainty regarding whether bondholders will choose to convert their bonds and the specific timing and quantity of such conversions [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 苏州丰倍生物科技股份有限公司（以下简称"公司"）股票于2026年2月4日、2月5日连续2个交易日内 日收盘价格涨幅偏离值累计超过20%，根据《上海证券交易所交易规则》的有关规定，属于股票交易异 常波动情形。 ● 经公司自查，并向公司控股股东、实际控制人发问询函，截至本公告披露日，除公司已披露的事项 外，不存在其他应披露而未披露的重大信息。 ● 公司股价短期波动幅度较大，敬请广大投资者理性决策，注意投资风险。 一、股票交易异常波动的具体情况 公司股票交易于2026年2月4日、2月5日连续2个交易日内日收盘价格涨幅偏离值累计超过20%，根据 《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情形。 二、公司关注并核实的相关情况 （一）生产经营情况 经公司自查，公司目前生产经营活动一切正常，市场环境、行业政策没有发生重大调整、生产成本和销 售等情况没有出现大幅波动、内部生产经营秩序正常。 （二）重大事项情况 ...